Mode
Text Size
Log in / Sign up
N/A Completed N=100 Randomized Single-blind Treatment

Reducing CVD Risk in Caregivers: A Brief Behavioral Activation Intervention

Source: ClinicalTrials.gov NCT01802554 ↗
Enrolled (actual)
100
Serious AEs
0.0%
Results posted
Apr 2014
Primary outcomePrimary: Brief Center for Epidemiologic Studies Depression Scale (CESD) — -3.46; -1.26 units on a scale — p=.039

Summary

Cardiovascular disease and depression are some of the most costly illnesses to society, and caring for a loved-one with Alzheimer's disease has been associated with increased risk for both depression and cardiovascular disease. Indeed, depressive symptoms have been linked with elevated plasma concentrations of D-dimer and Interleukin-6 (IL-6), both of which are associated with increased risk for cardiovascular disease (CVD). The present research tests a brief behavioral intervention for reducing both depressive symptoms and CVD biomarkers in Alzheimer caregivers. We hypothesize that caregivers receiving a brief Behavioral Activation (BA) therapy will show greater reductions in depressive symptoms and in CVD biomarkers relative to those randomized to a time-equivalent Information and Support (IS) therapy.

Outcome Measures

OutcomeResultp-value
PRIMARY
Brief Center for Epidemiologic Studies Depression Scale (CESD)
-3.46; -1.26 .039 sig
PRIMARY
D-dimer
-92.22; -61.0 .701
PRIMARY
Interleukin-6 (IL-6)
-0.58; 1.33 .04 sig
SECONDARY
Positive and Negative Affect Schedule
-3.43; -0.61 .021 sig

Eligibility Criteria

Inclusion Criteria

  • Aged 55 or older and providing at-home care for a care recipient (CR) with a physician-diagnosis of Alzheimer's disease (AD) or related dementia.

Exclusion Criteria

  • Receiving beta-blocking medications at enrollment
  • Receiving treatment with Anticoagulant medications
  • Severe hypertension (>200/120 mmHg)
  • Diagnosed with a terminal illness with a life expectancy <6 months
  • Enrolled in another intervention study
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01802554). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search